基本信息
views: 57
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Lai is Executive Director of Drug Metabolism at Gilead Sciences. His current role in Gilead is to manage DM-drug disposition labs, to implement in vitro/in vivo preclinical/clinical strategies for compound advancement to the market and product life-cycle management. Dr Lai is a Fellow of American Association of Pharmaceutical Scientists (AAPS) and holds an Adjunct Faculty position in the Department of Pharmacy of the University of Rhode Island. He received his M.D from Fujian Medical University in China and his Ph.D. (Toxicology) from Sapporo Medical University in Japan in 1998. From 1998 to 2001, he was a research fellow of Japanese Society for Promotion (JSPS) in Department of Physiopathology, Graduate School of Medicine of Hokkaido University, followed by a position as Research Associate in Department of Pharmaceutics, University of Washington. In 2004, he Joined pharmacokinetics, dynamics and metabolism (PDM), PGRD St. Louis and then moved to Groton in 2010, Pfizer Inc. and has been serving as a PDM representative (PI), postdoc supervisor and lab head for drug transporter research. In 2013, he joined BMS. He has been a research fellow and had a significant role in translational researches in transporter associated ADME-PK-Tox. In 2017, he moved to Gilead Science. He is a patent inventor and the author of a book, book chapters and over 130 original publications in the peer-reviewed journal. He is associate editor/editorial board member of top ranking DMPK journals including Frontier Pharmacology, DMD, BDD, JPS etc.
Research Interests
Papers共 226 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Drug Metabolism and Pharmacokinetics (2024): 100874
Helen E Rollison,Pallabi Mitra,Hugues Chanteux,Zhizhou Fang,Xiaomin Liang, Seong Hee Park,Chester Costales,Imad Hanna,Nilay Thakkar, James M Vergis,Daniel A J Bow,Kathleen M Hillgren,
Drug metabolism and disposition: the biological fate of chemicalspp.DMD-AR, (2024)
Drug metabolism and disposition: the biological fate of chemicalsno. 5 (2024): 432-441
Murali Subramanian, Aaliyah Shodeinde, Gregg Schwarzwalder, Ana Gonzalez, Josh Yu, Guangyu Zhao,Jia Hao,Xiaomin Liang,Yurong Lai,Raju Subramanian
Drug Metabolism and Pharmacokinetics (2024): 100989
Drug Metabolism and Pharmacokinetics (2024): 100874
Nature reviews. Drug discoveryno. 4 (2024): 255-280
The AAPS Journalno. 1 (2024): 1-12
Drug metabolism and disposition: the biological fate of chemicalsno. 6 (2024): 476-478
Helen E Rollison,Pallabi Mitra,Hugues Chanteux,Zhizhou Fang,Xiaomin Liang, Seong Hee Park,Chester Costales,Imad Hanna,Nilay Thakkar, James M Vergis,Daniel A J Bow,Kathleen M Hillgren,
Drug metabolism and disposition: the biological fate of chemicalsno. 7 (2024): 582-596
Load More
Author Statistics
#Papers: 0
#Citation: 0
H-Index: 0
G-Index: 0
Sociability: 0
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn